Kalyra Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2012-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://kalyrapharma.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Single and Multiple Ascending Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of KP-1199
Phase 1
Terminated
- Conditions
- Analgesia
- Interventions
- First Posted Date
- 2019-03-19
- Last Posted Date
- 2021-09-16
- Lead Sponsor
- Kalyra Pharmaceuticals, Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT03880487
- Locations
- 🇺🇸
PRA Health Sciences, Salt Lake City, Utah, United States
News
No news found